Heh heh.
But if you're talking about major players, a drug in ph3 that will be in the market years earlier and has shown 3x efficacy over the incumbent; i reckon ot deserves acknowledgement that it exists.
Unless you don't want to draw attention to a strong competitor...
CU6 - Media and Industry News, page-278
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.13 |
Change
0.560(10.1%) |
Mkt cap ! $1.910B | |||
| Open | High | Low | Value | Volume |
| $5.68 | $6.17 | $5.68 | $13.88M | 2.313M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 210 | $6.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.15 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |